When to Use Initial Triple Therapy in COPD: Adding a LAMA to ICS/LABA by Clinically Important Deterioration Assessment

PURPOSE: Triple therapy versus dual therapy for chronic pulmonary obstructive disease (COPD) can reduce symptoms, limit the risk of acute exacerbations (AEs) as well as improve lung function. Currently, studies that feature clinically important deterioration (CID) as a composite endpoint to assess t...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Wen-Chien, Wu, Biing-Ru, Liao, Wei-Chih, Chen, Chih-Yu, Chen, Wei-Chun, Hsia, Te-Chun, Tu, Chih-Yen, Chen, Chia-Hung, Hsu, Wu-Huei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7764554/
https://www.ncbi.nlm.nih.gov/pubmed/33376318
http://dx.doi.org/10.2147/COPD.S279482

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7764554/
https://www.ncbi.nlm.nih.gov/pubmed/33376318
http://dx.doi.org/10.2147/COPD.S279482

Ejemplares similares